Risk	B:C0035648
factors	I:C0035648
analyses	O
for	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
in	O
papillary	O
thyroid	I:C0238463
carcinomas	I:C0238463
:	O
a	O
retrospective	O
study	I:C0035363
of	O
356	O
patients	O
.	O

Risk	O
factors	I:C0035648
analyses	B:C0936012
for	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
in	O
papillary	O
thyroid	I:C0238463
carcinomas	I:C0238463
:	O
a	O
retrospective	O
study	I:C0035363
of	O
356	O
patients	O
.	O

Risk	O
factors	I:C0035648
analyses	O
for	O
lateral	B:C0686619
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
in	O
papillary	O
thyroid	I:C0238463
carcinomas	I:C0238463
:	O
a	O
retrospective	O
study	I:C0035363
of	O
356	O
patients	O
.	O

Risk	O
factors	I:C0035648
analyses	O
for	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
in	O
papillary	B:C0238463
thyroid	I:C0238463
carcinomas	I:C0238463
:	O
a	O
retrospective	O
study	I:C0035363
of	O
356	O
patients	O
.	O

Risk	O
factors	I:C0035648
analyses	O
for	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
in	O
papillary	O
thyroid	I:C0238463
carcinomas	I:C0238463
:	O
a	O
retrospective	B:C0035363
study	I:C0035363
of	O
356	O
patients	O
.	O

The	O
aim	O
of	O
this	O
study	B:C0035363
was	O
to	O
investigate	O
the	O
incidence	O
and	O
risk	O
factors	I:C0035648
for	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
(	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
)	O
in	O
patients	O
with	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
(	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
incidence	O
and	O
risk	B:C0035648
factors	I:C0035648
for	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
(	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
)	O
in	O
patients	O
with	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
(	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
incidence	O
and	O
risk	O
factors	I:C0035648
for	O
lateral	B:C0686619
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
(	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
)	O
in	O
patients	O
with	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
(	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
incidence	O
and	O
risk	O
factors	I:C0035648
for	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
(	O
lateral	B:C0686619
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
)	O
in	O
patients	O
with	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
(	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
incidence	O
and	O
risk	O
factors	I:C0035648
for	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
(	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
)	O
in	O
patients	O
with	O
papillary	B:C0238463
thyroid	I:C0238463
carcinoma	I:C0238463
(	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
)	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
incidence	O
and	O
risk	O
factors	I:C0035648
for	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
(	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
)	O
in	O
patients	O
with	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
(	O
papillary	B:C0238463
thyroid	I:C0238463
carcinoma	I:C0238463
)	O
.	O

356	O
patients	O
diagnosed	B:C0011900
with	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
who	O
underwent	O
total	O
thyroidectomy	I:C0193788
and	O
central	O
lymph	I:C3899695
node	I:C3899695
dissection	I:C3899695
and	O
lateral	O
lymph	O
node	I:C0242382
dissection	I:C0242382
between	O
January	O
2005	O
and	O
December	O
2011	O
were	O
enrolled	O
.	O

356	O
patients	O
diagnosed	O
with	O
papillary	B:C0238463
thyroid	I:C0238463
carcinoma	I:C0238463
who	O
underwent	O
total	O
thyroidectomy	I:C0193788
and	O
central	O
lymph	I:C3899695
node	I:C3899695
dissection	I:C3899695
and	O
lateral	O
lymph	O
node	I:C0242382
dissection	I:C0242382
between	O
January	O
2005	O
and	O
December	O
2011	O
were	O
enrolled	O
.	O

356	O
patients	O
diagnosed	O
with	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
who	O
underwent	O
total	B:C0193788
thyroidectomy	I:C0193788
and	O
central	O
lymph	I:C3899695
node	I:C3899695
dissection	I:C3899695
and	O
lateral	O
lymph	O
node	I:C0242382
dissection	I:C0242382
between	O
January	O
2005	O
and	O
December	O
2011	O
were	O
enrolled	O
.	O

356	O
patients	O
diagnosed	O
with	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
who	O
underwent	O
total	O
thyroidectomy	I:C0193788
and	O
central	B:C3899695
lymph	I:C3899695
node	I:C3899695
dissection	I:C3899695
and	O
lateral	O
lymph	O
node	I:C0242382
dissection	I:C0242382
between	O
January	O
2005	O
and	O
December	O
2011	O
were	O
enrolled	O
.	O

356	O
patients	O
diagnosed	O
with	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
who	O
underwent	O
total	O
thyroidectomy	I:C0193788
and	O
central	O
lymph	I:C3899695
node	I:C3899695
dissection	I:C3899695
and	O
lateral	B:C0205093
lymph	O
node	I:C0242382
dissection	I:C0242382
between	O
January	O
2005	O
and	O
December	O
2011	O
were	O
enrolled	O
.	O

356	O
patients	O
diagnosed	O
with	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
who	O
underwent	O
total	O
thyroidectomy	I:C0193788
and	O
central	O
lymph	I:C3899695
node	I:C3899695
dissection	I:C3899695
and	O
lateral	O
lymph	B:C0242382
node	I:C0242382
dissection	I:C0242382
between	O
January	O
2005	O
and	O
December	O
2011	O
were	O
enrolled	O
.	O

The	O
relation	O
between	O
lateral	B:C0686619
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
and	O
clinicopathological	O
features	O
such	O
as	O
gender	O
,	O
age	O
,	O
tumor	O
size	I:C0475440
,	O
tumor	O
spread	I:C1334939
,	O
psammoma	O
bodies	I:C0391863
,	O
tumor	O
multifocality	I:C1302461
,	O
extrathyroidal	O
extension	I:C3899369
(	O
extrathyroidal	O
extension	I:C3899369
)	O
,	O
unilateral	O
or	O
bilateral	O
disease	I:C1511113
,	O
tumor	O
primary	O
location	O
and	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
(	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
)	O
was	O
analyzed	O
.	O

The	O
relation	O
between	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
and	O
clinicopathological	O
features	O
such	O
as	O
gender	O
,	O
age	O
,	O
tumor	B:C0475440
size	I:C0475440
,	O
tumor	O
spread	I:C1334939
,	O
psammoma	O
bodies	I:C0391863
,	O
tumor	O
multifocality	I:C1302461
,	O
extrathyroidal	O
extension	I:C3899369
(	O
extrathyroidal	O
extension	I:C3899369
)	O
,	O
unilateral	O
or	O
bilateral	O
disease	I:C1511113
,	O
tumor	O
primary	O
location	O
and	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
(	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
)	O
was	O
analyzed	O
.	O

The	O
relation	O
between	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
and	O
clinicopathological	O
features	O
such	O
as	O
gender	O
,	O
age	O
,	O
tumor	O
size	I:C0475440
,	O
tumor	B:C1334939
spread	I:C1334939
,	O
psammoma	O
bodies	I:C0391863
,	O
tumor	O
multifocality	I:C1302461
,	O
extrathyroidal	O
extension	I:C3899369
(	O
extrathyroidal	O
extension	I:C3899369
)	O
,	O
unilateral	O
or	O
bilateral	O
disease	I:C1511113
,	O
tumor	O
primary	O
location	O
and	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
(	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
)	O
was	O
analyzed	O
.	O

The	O
relation	O
between	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
and	O
clinicopathological	O
features	O
such	O
as	O
gender	O
,	O
age	O
,	O
tumor	O
size	I:C0475440
,	O
tumor	O
spread	I:C1334939
,	O
psammoma	B:C0391863
bodies	I:C0391863
,	O
tumor	O
multifocality	I:C1302461
,	O
extrathyroidal	O
extension	I:C3899369
(	O
extrathyroidal	O
extension	I:C3899369
)	O
,	O
unilateral	O
or	O
bilateral	O
disease	I:C1511113
,	O
tumor	O
primary	O
location	O
and	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
(	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
)	O
was	O
analyzed	O
.	O

The	O
relation	O
between	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
and	O
clinicopathological	O
features	O
such	O
as	O
gender	O
,	O
age	O
,	O
tumor	O
size	I:C0475440
,	O
tumor	O
spread	I:C1334939
,	O
psammoma	O
bodies	I:C0391863
,	O
tumor	B:C1302461
multifocality	I:C1302461
,	O
extrathyroidal	O
extension	I:C3899369
(	O
extrathyroidal	O
extension	I:C3899369
)	O
,	O
unilateral	O
or	O
bilateral	O
disease	I:C1511113
,	O
tumor	O
primary	O
location	O
and	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
(	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
)	O
was	O
analyzed	O
.	O

The	O
relation	O
between	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
and	O
clinicopathological	O
features	O
such	O
as	O
gender	O
,	O
age	O
,	O
tumor	O
size	I:C0475440
,	O
tumor	O
spread	I:C1334939
,	O
psammoma	O
bodies	I:C0391863
,	O
tumor	O
multifocality	I:C1302461
,	O
extrathyroidal	B:C3899369
extension	I:C3899369
(	O
extrathyroidal	O
extension	I:C3899369
)	O
,	O
unilateral	O
or	O
bilateral	O
disease	I:C1511113
,	O
tumor	O
primary	O
location	O
and	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
(	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
)	O
was	O
analyzed	O
.	O

The	O
relation	O
between	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
and	O
clinicopathological	O
features	O
such	O
as	O
gender	O
,	O
age	O
,	O
tumor	O
size	I:C0475440
,	O
tumor	O
spread	I:C1334939
,	O
psammoma	O
bodies	I:C0391863
,	O
tumor	O
multifocality	I:C1302461
,	O
extrathyroidal	O
extension	I:C3899369
(	O
extrathyroidal	B:C3899369
extension	I:C3899369
)	O
,	O
unilateral	O
or	O
bilateral	O
disease	I:C1511113
,	O
tumor	O
primary	O
location	O
and	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
(	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
)	O
was	O
analyzed	O
.	O

The	O
relation	O
between	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
and	O
clinicopathological	O
features	O
such	O
as	O
gender	O
,	O
age	O
,	O
tumor	O
size	I:C0475440
,	O
tumor	O
spread	I:C1334939
,	O
psammoma	O
bodies	I:C0391863
,	O
tumor	O
multifocality	I:C1302461
,	O
extrathyroidal	O
extension	I:C3899369
(	O
extrathyroidal	O
extension	I:C3899369
)	O
,	O
unilateral	O
or	O
bilateral	B:C1511113
disease	I:C1511113
,	O
tumor	O
primary	O
location	O
and	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
(	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
)	O
was	O
analyzed	O
.	O

The	O
relation	O
between	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
and	O
clinicopathological	O
features	O
such	O
as	O
gender	O
,	O
age	O
,	O
tumor	O
size	I:C0475440
,	O
tumor	O
spread	I:C1334939
,	O
psammoma	O
bodies	I:C0391863
,	O
tumor	O
multifocality	I:C1302461
,	O
extrathyroidal	O
extension	I:C3899369
(	O
extrathyroidal	O
extension	I:C3899369
)	O
,	O
unilateral	O
or	O
bilateral	O
disease	I:C1511113
,	O
tumor	B:C0027651
primary	O
location	O
and	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
(	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
)	O
was	O
analyzed	O
.	O

The	O
relation	O
between	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
and	O
clinicopathological	O
features	O
such	O
as	O
gender	O
,	O
age	O
,	O
tumor	O
size	I:C0475440
,	O
tumor	O
spread	I:C1334939
,	O
psammoma	O
bodies	I:C0391863
,	O
tumor	O
multifocality	I:C1302461
,	O
extrathyroidal	O
extension	I:C3899369
(	O
extrathyroidal	O
extension	I:C3899369
)	O
,	O
unilateral	O
or	O
bilateral	O
disease	I:C1511113
,	O
tumor	O
primary	O
location	B:C0450429
and	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
(	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
)	O
was	O
analyzed	O
.	O

The	O
relation	O
between	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
and	O
clinicopathological	O
features	O
such	O
as	O
gender	O
,	O
age	O
,	O
tumor	O
size	I:C0475440
,	O
tumor	O
spread	I:C1334939
,	O
psammoma	O
bodies	I:C0391863
,	O
tumor	O
multifocality	I:C1302461
,	O
extrathyroidal	O
extension	I:C3899369
(	O
extrathyroidal	O
extension	I:C3899369
)	O
,	O
unilateral	O
or	O
bilateral	O
disease	I:C1511113
,	O
tumor	O
primary	O
location	O
and	O
central	B:C0686619
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
(	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
)	O
was	O
analyzed	O
.	O

The	O
relation	O
between	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
and	O
clinicopathological	O
features	O
such	O
as	O
gender	O
,	O
age	O
,	O
tumor	O
size	I:C0475440
,	O
tumor	O
spread	I:C1334939
,	O
psammoma	O
bodies	I:C0391863
,	O
tumor	O
multifocality	I:C1302461
,	O
extrathyroidal	O
extension	I:C3899369
(	O
extrathyroidal	O
extension	I:C3899369
)	O
,	O
unilateral	O
or	O
bilateral	O
disease	I:C1511113
,	O
tumor	O
primary	O
location	O
and	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
(	O
central	B:C0686619
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
)	O
was	O
analyzed	O
.	O

The	O
relation	O
between	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
and	O
clinicopathological	O
features	O
such	O
as	O
gender	O
,	O
age	O
,	O
tumor	O
size	I:C0475440
,	O
tumor	O
spread	I:C1334939
,	O
psammoma	O
bodies	I:C0391863
,	O
tumor	O
multifocality	I:C1302461
,	O
extrathyroidal	O
extension	I:C3899369
(	O
extrathyroidal	O
extension	I:C3899369
)	O
,	O
unilateral	O
or	O
bilateral	O
disease	I:C1511113
,	O
tumor	O
primary	O
location	O
and	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
(	O
central	O
lymph	I:C0686619
node	I:C0686619
metastases	I:C0686619
)	O
was	O
analyzed	B:C0936012
.	O

The	O
rate	O
of	O
lateral	B:C0686619
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
was	O
75.0	O
%	O
.	O

In	O
the	O
univariate	O
analysis	O
,	O
it	O
was	O
significantly	O
associated	O
with	O
age	O
,	O
tumor	B:C0475440
size	I:C0475440
,	O
tumor	O
spread	I:C1334939
,	O
extrathyroidal	O
extension	I:C3899369
,	O
primary	O
tumor	O
location	O
and	O
central	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
(	O
p	O
<	O
0.05	O
)	O
.	O

In	O
the	O
univariate	O
analysis	O
,	O
it	O
was	O
significantly	O
associated	O
with	O
age	O
,	O
tumor	O
size	I:C0475440
,	O
tumor	B:C1334939
spread	I:C1334939
,	O
extrathyroidal	O
extension	I:C3899369
,	O
primary	O
tumor	O
location	O
and	O
central	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
(	O
p	O
<	O
0.05	O
)	O
.	O

In	O
the	O
univariate	O
analysis	O
,	O
it	O
was	O
significantly	O
associated	O
with	O
age	O
,	O
tumor	O
size	I:C0475440
,	O
tumor	O
spread	I:C1334939
,	O
extrathyroidal	B:C3899369
extension	I:C3899369
,	O
primary	O
tumor	O
location	O
and	O
central	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
(	O
p	O
<	O
0.05	O
)	O
.	O

In	O
the	O
univariate	O
analysis	O
,	O
it	O
was	O
significantly	O
associated	O
with	O
age	O
,	O
tumor	O
size	I:C0475440
,	O
tumor	O
spread	I:C1334939
,	O
extrathyroidal	O
extension	I:C3899369
,	O
primary	O
tumor	B:C0027651
location	O
and	O
central	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
(	O
p	O
<	O
0.05	O
)	O
.	O

In	O
the	O
univariate	O
analysis	O
,	O
it	O
was	O
significantly	O
associated	O
with	O
age	O
,	O
tumor	O
size	I:C0475440
,	O
tumor	O
spread	I:C1334939
,	O
extrathyroidal	O
extension	I:C3899369
,	O
primary	O
tumor	O
location	B:C0450429
and	O
central	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
(	O
p	O
<	O
0.05	O
)	O
.	O

In	O
the	O
univariate	O
analysis	O
,	O
it	O
was	O
significantly	O
associated	O
with	O
age	O
,	O
tumor	O
size	I:C0475440
,	O
tumor	O
spread	I:C1334939
,	O
extrathyroidal	O
extension	I:C3899369
,	O
primary	O
tumor	O
location	O
and	O
central	B:C0686619
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
(	O
p	O
<	O
0.05	O
)	O
.	O

In	O
contrast	O
,	O
in	O
the	O
multivariate	O
analysis	O
,	O
it	O
was	O
significantly	O
associated	O
with	O
primary	O
tumor	B:C0027651
location	O
,	O
central	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
(	O
p	O
<	O
0.05	O
)	O
and	O
tumor	O
size	I:C0475440
>	O
1.5	O
cm	O
with	O
p	O
=	O
0.05	O
but	O
was	O
unrelated	O
to	O
the	O
other	O
factors	O
.	O

In	O
contrast	O
,	O
in	O
the	O
multivariate	O
analysis	O
,	O
it	O
was	O
significantly	O
associated	O
with	O
primary	O
tumor	O
location	B:C0450429
,	O
central	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
(	O
p	O
<	O
0.05	O
)	O
and	O
tumor	O
size	I:C0475440
>	O
1.5	O
cm	O
with	O
p	O
=	O
0.05	O
but	O
was	O
unrelated	O
to	O
the	O
other	O
factors	O
.	O

In	O
contrast	O
,	O
in	O
the	O
multivariate	O
analysis	O
,	O
it	O
was	O
significantly	O
associated	O
with	O
primary	O
tumor	O
location	O
,	O
central	B:C0686619
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
(	O
p	O
<	O
0.05	O
)	O
and	O
tumor	O
size	I:C0475440
>	O
1.5	O
cm	O
with	O
p	O
=	O
0.05	O
but	O
was	O
unrelated	O
to	O
the	O
other	O
factors	O
.	O

In	O
contrast	O
,	O
in	O
the	O
multivariate	O
analysis	O
,	O
it	O
was	O
significantly	O
associated	O
with	O
primary	O
tumor	O
location	O
,	O
central	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
(	O
p	O
<	O
0.05	O
)	O
and	O
tumor	B:C0475440
size	I:C0475440
>	O
1.5	O
cm	O
with	O
p	O
=	O
0.05	O
but	O
was	O
unrelated	O
to	O
the	O
other	O
factors	O
.	O

Patients	O
with	O
papillary	B:C0238463
thyroid	I:C0238463
carcinoma	I:C0238463
,	O
with	O
the	O
primary	O
tumor	O
located	O
in	O
the	O
upper	O
part	O
of	O
the	O
lobe	O
and	O
positive	O
central	O
compartment	O
lymph	O
node	I:C0686619
metastasis	I:C0686619
with	O
a	O
tumor	O
size	I:C0475440
>	O
1.5	O
cm	O
diameter	O
are	O
more	O
likely	O
to	O
have	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
.	O

Patients	O
with	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
,	O
with	O
the	O
primary	O
tumor	B:C0027651
located	O
in	O
the	O
upper	O
part	O
of	O
the	O
lobe	O
and	O
positive	O
central	O
compartment	O
lymph	O
node	I:C0686619
metastasis	I:C0686619
with	O
a	O
tumor	O
size	I:C0475440
>	O
1.5	O
cm	O
diameter	O
are	O
more	O
likely	O
to	O
have	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
.	O

Patients	O
with	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
,	O
with	O
the	O
primary	O
tumor	O
located	B:C0450429
in	O
the	O
upper	O
part	O
of	O
the	O
lobe	O
and	O
positive	O
central	O
compartment	O
lymph	O
node	I:C0686619
metastasis	I:C0686619
with	O
a	O
tumor	O
size	I:C0475440
>	O
1.5	O
cm	O
diameter	O
are	O
more	O
likely	O
to	O
have	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
.	O

Patients	O
with	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
,	O
with	O
the	O
primary	O
tumor	O
located	O
in	O
the	O
upper	O
part	O
of	O
the	O
lobe	B:C0796494
and	O
positive	O
central	O
compartment	O
lymph	O
node	I:C0686619
metastasis	I:C0686619
with	O
a	O
tumor	O
size	I:C0475440
>	O
1.5	O
cm	O
diameter	O
are	O
more	O
likely	O
to	O
have	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
.	O

Patients	O
with	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
,	O
with	O
the	O
primary	O
tumor	O
located	O
in	O
the	O
upper	O
part	O
of	O
the	O
lobe	O
and	O
positive	B:C1446409
central	O
compartment	O
lymph	O
node	I:C0686619
metastasis	I:C0686619
with	O
a	O
tumor	O
size	I:C0475440
>	O
1.5	O
cm	O
diameter	O
are	O
more	O
likely	O
to	O
have	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
.	O

Patients	O
with	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
,	O
with	O
the	O
primary	O
tumor	O
located	O
in	O
the	O
upper	O
part	O
of	O
the	O
lobe	O
and	O
positive	O
central	O
compartment	O
lymph	B:C0686619
node	I:C0686619
metastasis	I:C0686619
with	O
a	O
tumor	O
size	I:C0475440
>	O
1.5	O
cm	O
diameter	O
are	O
more	O
likely	O
to	O
have	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
.	O

Patients	O
with	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
,	O
with	O
the	O
primary	O
tumor	O
located	O
in	O
the	O
upper	O
part	O
of	O
the	O
lobe	O
and	O
positive	O
central	O
compartment	O
lymph	O
node	I:C0686619
metastasis	I:C0686619
with	O
a	O
tumor	B:C0475440
size	I:C0475440
>	O
1.5	O
cm	O
diameter	O
are	O
more	O
likely	O
to	O
have	O
lateral	O
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
.	O

Patients	O
with	O
papillary	O
thyroid	I:C0238463
carcinoma	I:C0238463
,	O
with	O
the	O
primary	O
tumor	O
located	O
in	O
the	O
upper	O
part	O
of	O
the	O
lobe	O
and	O
positive	O
central	O
compartment	O
lymph	O
node	I:C0686619
metastasis	I:C0686619
with	O
a	O
tumor	O
size	I:C0475440
>	O
1.5	O
cm	O
diameter	O
are	O
more	O
likely	O
to	O
have	O
lateral	B:C0686619
lymph	I:C0686619
node	I:C0686619
metastasis	I:C0686619
.	O

Therefore	O
,	O
more	O
meticulous	B:C0220825
evaluations	I:C0220825
including	O
the	O
lateral	O
lymph	O
nodes	I:C0024204
should	O
be	O
performed	O
before	O
surgery	O
.	O

Therefore	O
,	O
more	O
meticulous	O
evaluations	I:C0220825
including	O
the	O
lateral	B:C0205093
lymph	O
nodes	I:C0024204
should	O
be	O
performed	O
before	O
surgery	O
.	O

Therefore	O
,	O
more	O
meticulous	O
evaluations	I:C0220825
including	O
the	O
lateral	O
lymph	B:C0024204
nodes	I:C0024204
should	O
be	O
performed	O
before	O
surgery	O
.	O

Therefore	O
,	O
more	O
meticulous	O
evaluations	I:C0220825
including	O
the	O
lateral	O
lymph	O
nodes	I:C0024204
should	O
be	O
performed	O
before	O
surgery	B:C0543467
.	O

